Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?Citation formats

Standard

Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19? / Pilkington, S M; Watson, R E B.

In: The British journal of dermatology, Vol. 185, No. 6, 12.2021, p. 1090-1091.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{7f9d007b5fb94d4a9684058917717c50,
title = "Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?",
keywords = "Antiviral Agents, COVID-19, Chilblains/diagnosis, Humans, Interferons, SARS-CoV-2",
author = "Pilkington, {S M} and Watson, {R E B}",
year = "2021",
month = dec,
doi = "10.1111/bjd.20784",
language = "English",
volume = "185",
pages = "1090--1091",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "John Wiley & Sons Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?

AU - Pilkington, S M

AU - Watson, R E B

PY - 2021/12

Y1 - 2021/12

KW - Antiviral Agents

KW - COVID-19

KW - Chilblains/diagnosis

KW - Humans

KW - Interferons

KW - SARS-CoV-2

U2 - 10.1111/bjd.20784

DO - 10.1111/bjd.20784

M3 - Article

C2 - 34748213

VL - 185

SP - 1090

EP - 1091

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -